The June deficit fell for the second month in a row, but that doesn’t mean the U.S. is not on track for another trillion-dollar trade gap with the world. China remains largest single source of the trade deficit.
This summer saw a host of amendments in defense bills to restrict investment in China. Will the rhetoric be met with action?
China companies are put on Entity Lists for being in breach of certain laws. In this case, allegations of forced labor. That doesn’t stop U.S. investors from buying their stocks.
The majority of the Senate supports this legislation, and we will be working with lawmakers in the House to ensure this bill becomes law.
Companies continue to invest in domestic solar thanks to all the new renewable energy tax credits. Without them, and tariffs, US solar would be China owned.
In latest House Select Committee on the CCP, outbound investment restrictions get favorable view.
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
Should federal government employees, including military commanders, be investing their retirement money in China? Some say no, and will try to stop it this week.
The House Select Committee on the CCP held a debate this week with opposing teams arguing for ways to restrict outbound investment to China, including going after Silicon Valley venture capital firms.
Big trouble in China as Washington increasingly warns American businesses to “stay at your own risks”.
